The UK account notes early trial results for the weight-loss injection look striking, but cautions people against taking it based on word of mouth.
Recap by typeshit. Post by @houseofhealth.uk on Instagram.
The Washington Post looks at why so many users report shedding, a problem now nicknamed "Ozempic hair," and what new research suggests about the cause.
She says GLP-1 drugs slow how fast the stomach empties. That can let stomach contents reach the lungs during sedation, even after fasting.
The endocrinologist cautions that an interesting effect seen in animals does not mean a compound is suitable for human use.
The account calls the up to 28% weight loss impressive but says only about half of participants finished, citing nausea, constipation and skin sensitivity.
Fractyl's new catheter patent runs to 2042 as the company heads toward an FDA De Novo submission, backed by its positive six-month REMAIN-1 results.
A Northeast Ohio practitioner says this choice comes up first in most visits, noting tirzepatide acts on both GLP-1 and GIP receptors.
Loading…